Le Lézard
Classified in: Health
Subject: FDA

Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure® for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs



MARLBOROUGH, Mass., June 15, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product, SculpSure, to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of the abdomen and love handles (flanks).

SculpSure is a clinically proven, non-surgical body contouring (lipolysis) treatment designed to permanently eliminate fat cells in problem areas. Developed by Cynosure, a world leader in medical aesthetics and division of Hologic, SculpSure utilizes a selective wavelength laser that precisely targets fat cells under the skin. The laser raises the temperature of body fat to disrupt and destroy these cells, which are naturally eliminated over time and do not return. Patients are able to achieve desired results ? without downtime or surgery ? through customized treatment plans, each lasting only 25 minutes.

"The approval of SculpSure to treat back fat and the inner and outer thighs is a direct response to the growing needs of our consumers, who are looking to achieve a slimmer appearance and enhance the body they work hard to maintain," said Michael Davin, Divisional President of Cynosure at Hologic. "Cynosure is a leader in medical aesthetics and pioneer in light-based fat reduction, and we expect the addition of three known body problem areas to SculpSure's already advanced, versatile treatment to further drive demand and pave the way for future innovations."

To learn more about SculpSure, please visit www.SculpSure.com.

About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.  For more information on Hologic, visit www.hologic.com.

Hologic, The Science of Sure and SculpSure are registered trademarks of Hologic, Inc. in the United States and/or other countries.

Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

Media Contact
Jane Mazur 
508.263.8764 (direct) 
585.355.5978 (mobile) 
jane.mazur@hologic.com

Investor Contact
Michael Watts 
858.410.8588 
michael.watts@hologic.com

SOURCE Hologic, Inc.


These press releases may also interest you

at 15:33
TORONTO, ON--(Marketwired - October 20, 2017) - Van der Pop (VdP), North America's leading female-focused cannabis brand, is pleased to announce its two branded strains of cannabis will be available for purchase by the end of November, in...

at 15:29
VANCOUVER, Oct. 20, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will mark the one-year anniversary of the Healthy Eating Strategy by highlighting the progress that has been made to date during her keynote address...

at 15:24
Significant progress achieved in plan to make healthier food choices easier for Canadians    VANCOUVER, Oct. 20, 2017 /CNW/ - Canada is facing a diet-related chronic disease crisis. To address this issue, the Government of Canada is implementing a...

at 15:15
PHOENIX, Oct. 20, 2017 /PRNewswire/ -- For years, chiropractors have used chiropractic manipulation to create positive effects for many patients. A recent study, first published in Calcified Tissue International, offers new, empirical data looking...

at 14:19
STOCKHOLM, October 20, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that data from the initial phase IIa study of MIV-711 in patients with moderate knee osteoarthritis have been selected for late-breaking presentation at the...

at 14:00
MONTREAL, Oct. 20, 2017 /CNW Telbec/ - Technoparc Montréal and FPInnovations today concluded the purchase of lands by FPInnovations for its establishment at the Technoparc de Montréal. The lands, totaling more than 360,000 square feet (33,400 square...




News published on 15 june 2017 at 08:00 and distributed by: